Ken Griffin Synaptogenix, Inc. Put Options Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding SNPX
# of Institutions
25Shares Held
955KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny401KShares$1.81 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$696,6640.0% of portfolio
-
Two Sigma Securities, LLC New York, NY83.4KShares$376,1740.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA68.5KShares$309,0340.0% of portfolio
-
Cannell & Co. New York, NY30KShares$135,3000.0% of portfolio
About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $30.9M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...